Mobocertinib is for people with NSCLC and a certain kind of EGFR mutation. It works by aiming at the EGFR, which helps slow down cancer cell growth. The formulation comes in 40 mg capsules, and the recommended dosage is 160 mg per day, which can be taken with or without food.
One bottle holds 90 of these little capsules. The way it works is it sticks to a protein called EGFR and stops the stuff that makes cancer cells keep growing, divide, and hang on to life.
